Healthcare & Life Sciences
MercyBio
United Statesmercybio.com/
MercyBio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About MercyBio
MercyBio is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
MercyBio develops blood-based early cancer detection tests using their patented Mercy Halo™ platform, which leverages extracellular vesicles and low-cost qPCR technology to identify cancer-associated biomarkers with high sensitivity and specificity.
Explore MercyBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.